Amgen has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol.» Read More
Thousands of patients claim marijuana provides them relief from devastating symptoms. We asked High Times Cultivation Editor Danny Danko to put a cost on this relief.
The marketplace for narcotics isn’t what it used to be. Read ahead to see a list of dangerous drugs that are legal in many American states.
When policy makers in Washington worry about Mexico these days, they think in terms of a handful of numbers: Mexico’s 19,500 hectares devoted to poppy cultivation for heroin; its 17,500 hectares growing cannabis; the 95 percent of American cocaine imports brought by Mexican cartels through Mexico and Central America, the New York Times reports.
Roger Clemens has been acquitted on all charges by a jury that decided he didn't lie to Congress when he denied using performance-enhancing drugs.
Looking to short the euro? You could buy shares of Sanofi, the world’s fourth-largest drug company by sales, because of its limited exposure to Europe.
Two companies have teamed up to market fingerprint-based drug testing to police, prisons, and, they hope, American companies.
On Friday, Alaska Distillery seeks to capitalize on the cannabis celebrations as it officially launches the country’s first hemp-seed vodka.
It is long past time for politicians at all levels to end this bankrupt policy of Prohibition, and stop breaking down the doors of Americans who only want to possess a harmless plant in the comfort of their own homes.
Pot should remain as a controlled substance, with marijuana-based medicines (like cocaine-based medicines) available by subscription fulfilled not from your home-grown stash but through a pharmacy, contends Bob Enyart, pastor of the Denver Bible Church.
Several states with dispensaries have seen an increase in both arrests and the confiscation of marijuana plants. However, a look at DEA records shows what appears to be an uneven enforcement policy among pot-friendly states over the past several years.
So what argument should advocates employ? That the government has no business interfering in private activities except to prevent harm to others
The shutdown of Oaksterdam University was another in an ongoing dispute between federal and local officials in California on the topic of marijuana laws. It's one that has been escalating over the past year – but so far discussions between the state and feds have been rare.
More than two years after New Jersey approved a measure to legalize marijuana for chronically ill patients, the program may finally be on the verge of allowing dispensaries to open.
Not only was Oregon the first state to decriminalize pot in 1973, years before its glamorous neighbor to the south, but its medical marijuana program has operated with few glitches since it began in 1998. Now, it's an issue in a top statewide election race.
Eli Lilly hopes one of its dyes, used to determine whether someone may have Alzheimer's disease, will counter the expected lost income loss income from losing patents on some of its best-selling drugs, the CEO said on CNBC Thursday.
The promise of low-cost gene sequencing could lead to a new era of personalized medicine, yielding new approaches for treating cancers and other serious diseases. The New York Times reports.
The Indonesian airline industry has made progress toward mending its reputation — amid soaring demand — after a series of spectacular crashes in recent years drew international attention to the country’s poor safety record. Now it has a new problem to deal with: drug abuse among its pilots. The NYT reports.
Two American brothers of a Mexican casino magnate who fled drug and fraud charges in the United States and has been seeking a pardon enabling him to return have emerged as major fund-raisers and donors for President Obama’s re-election campaign, The New York Times reports.
Americans have not increased spending on healthcare since 2009, according to a National Health Expenditures report.
Pharmaceutical giants’ profits could take a "double-dip" hit next year from patent expirations on blockbuster drugs and President Barack Obama’s healthcare reforms, according to a report from CreditSights, a credit market research firm.